102 related articles for article (PubMed ID: 1592746)
21. Attenuation of platelet-activating factor induced bronchoconstriction by nedocromil sodium.
Hayes JP; Chung KF; Barnes PJ
Eur Respir J; 1992 Nov; 5(10):1193-6. PubMed ID: 1336735
[TBL] [Abstract][Full Text] [Related]
22. Effect of platelet-activating factor receptor antagonism on endotoxin-induced lung dysfunction in awake sheep.
Christman BW; Lefferts PL; Blair IA; Snapper JR
Am Rev Respir Dis; 1990 Dec; 142(6 Pt 1):1272-8. PubMed ID: 2174655
[TBL] [Abstract][Full Text] [Related]
23. Inhibition of antigen-induced airway hyperresponsiveness by ultralow molecular-weight heparin.
Molinari JF; Campo C; Shakir S; Ahmed T
Am J Respir Crit Care Med; 1998 Mar; 157(3 Pt 1):887-93. PubMed ID: 9517607
[TBL] [Abstract][Full Text] [Related]
24. Biochemical and pharmacological activities of SR 27417, a highly potent, long-acting platelet-activating factor receptor antagonist.
Herbert JM; Bernat A; Valette G; Gigo V; Lale A; LaPlace MC; Lespy L; Savi P; Maffrand JP; Le Fur G
J Pharmacol Exp Ther; 1991 Oct; 259(1):44-51. PubMed ID: 1656029
[TBL] [Abstract][Full Text] [Related]
25. Mechanisms of platelet activating factor-induced changes in sheep tracheal blood flow.
Corfield DR; Webber SE; Widdicombe JG
Br J Pharmacol; 1991 Jul; 103(3):1740-4. PubMed ID: 1657266
[TBL] [Abstract][Full Text] [Related]
26. Effects of inhaled heparin on immunologic and nonimmunologic bronchoconstrictor responses in sheep.
Ahmed T; Abraham WM; D'Brot J
Am Rev Respir Dis; 1992 Mar; 145(3):566-70. PubMed ID: 1546836
[TBL] [Abstract][Full Text] [Related]
27. Activation of capsaicin-sensitive sensory fibers modulates PAF-induced bronchial hyperresponsiveness in anesthetized guinea pigs.
Perretti F; Manzini S
Am Rev Respir Dis; 1993 Oct; 148(4 Pt 1):927-31. PubMed ID: 7692777
[TBL] [Abstract][Full Text] [Related]
28. Airway responsiveness in transgenic mice overexpressing platelet-activating factor receptor. Roles of thromboxanes and leukotrienes.
Nagase T; Ishii S; Katayama H; Fukuchi Y; Ouchi Y; Shimizu T
Am J Respir Crit Care Med; 1997 Nov; 156(5):1621-7. PubMed ID: 9372685
[TBL] [Abstract][Full Text] [Related]
29. Indomethacin and FPL-57231 inhibit antigen-induced airway hyperresponsiveness in sheep.
Lanes S; Stevenson JS; Codias E; Hernandez A; Sielczak MW; Wanner A; Abraham WM
J Appl Physiol (1985); 1986 Sep; 61(3):864-72. PubMed ID: 3093455
[TBL] [Abstract][Full Text] [Related]
30. Effect of heparin and a low-molecular weight heparinoid on PAF-induced airway responses in neonatally immunized rabbits.
Sasaki M; Herd CM; Page CP
Br J Pharmacol; 1993 Sep; 110(1):107-12. PubMed ID: 7693273
[TBL] [Abstract][Full Text] [Related]
31. Inhibition of allergic late airway responses by inhaled heparin-derived oligosaccharides.
Ahmed T; Ungo J; Zhou M; Campo C
J Appl Physiol (1985); 2000 May; 88(5):1721-9. PubMed ID: 10797135
[TBL] [Abstract][Full Text] [Related]
32. CV6209 inhibits airway wall thickening and airway hyperresponsiveness to histamine induced by intravenous administration of platelet-activating factor in guinea pigs.
Kurosawa M; Tsukagoshi H; Igarashi Y; Miyachi Y
J Lipid Mediat Cell Signal; 1996 Mar; 13(2):139-49. PubMed ID: 8925195
[TBL] [Abstract][Full Text] [Related]
33. Pharmacologic activity of bepafant (WEB 2170), a new and selective hetrazepinoic antagonist of platelet activating factor.
Heuer HO; Casals-Stenzel J; Muacevic G; Weber KH
J Pharmacol Exp Ther; 1990 Dec; 255(3):962-8. PubMed ID: 2262914
[TBL] [Abstract][Full Text] [Related]
34. Effects of a novel PAF antagonist, E6123, on PAF-induced biological responses.
Tsunoda H; Sakuma Y; Harada K; Muramoto K; Katayama S; Horie T; Shimomura N; Clark R; Miyazawa S; Okano K
Agents Actions Suppl; 1990; 31():251-4. PubMed ID: 2080757
[TBL] [Abstract][Full Text] [Related]
35. [Effects of anti-PAF agents on nasal response after allergen challenge in guinea pigs].
Narita S; Asakura K; Shirasaki H; Kojima T; Saitoh H; Kataura A
Nihon Jibiinkoka Gakkai Kaiho; 1992 Aug; 95(8):1190-7. PubMed ID: 1357119
[TBL] [Abstract][Full Text] [Related]
36. [Involvement of platelet activating factor (PAF) in ovalbumin antigen-induced late asthmatic response and increase of airway hyperresponsiveness in a guinea pig experimental model of asthma].
Arima M; Yukawa T; Terashi Y; Sagara H; Makino S
Arerugi; 1991 Feb; 40(2):141-6. PubMed ID: 2069513
[TBL] [Abstract][Full Text] [Related]
37. Effects of inhaled leukotriene D4 and platelet-activating factor on airway reactivity in normal subjects.
Kaye MG; Smith LJ
Am Rev Respir Dis; 1990 Apr; 141(4 Pt 1):993-7. PubMed ID: 2183659
[TBL] [Abstract][Full Text] [Related]
38. Pulmonary vascular response to platelet-activating factor in awake sheep and the role of cyclooxygenase metabolites.
Burhop KE; van der Zee H; Bizios R; Kaplan JE; Malik AB
Am Rev Respir Dis; 1986 Sep; 134(3):548-54. PubMed ID: 3752711
[TBL] [Abstract][Full Text] [Related]
39. [Effects of inhaled aerosol of platelet activating factor on pulmonary function and airway responsiveness in normal subjects].
Li Q
Zhonghua Jie He He Hu Xi Za Zhi; 1992 Aug; 15(4):222-4, 255. PubMed ID: 1307517
[TBL] [Abstract][Full Text] [Related]
40. Mechanism of platelet activating factor-induced bronchoconstriction in humans.
Smith LJ; Rubin AH; Patterson R
Am Rev Respir Dis; 1988 May; 137(5):1015-9. PubMed ID: 3195800
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
